Clinical Trial Update: Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 study assessing dynamic magnetic resonance imaging in patients with recurrent high-grade glioma receiving chemotherapy; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• High-grade Glioma

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Brain Neoplasms | Phase 1 | Status: TERMINATED